Profound Medical Stock Price

-0.23 (-1.2%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Profound Medical Corporation PROF NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.23 -1.2% 18.96 16:30:00
Open Price Low Price High Price Close Price Prev Close
19.24 18.40 19.24 18.96 19.19
Bid Price Ask Price Spread News
18.16 24.95 6.79 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
326 23,037 $ 18.71 $ 430,910 46,084 11.65 - 28.97
Last Trade Time Type Quantity Stock Price Currency
16:00:00 109 $ 18.96 USD

Profound Medical Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 385.78M 20.35M 20.35M $ 6.92M $ - -1.29 -12.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Profound Medical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PROF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week18.0019.3117.9018.5920,9490.965.33%
1 Month17.1019.3116.9318.1428,6891.8610.88%
3 Months22.1222.39516.0018.9653,190-3.16-14.29%
6 Months18.0028.9716.0022.2171,7360.965.33%
1 Year12.1628.9711.6519.2078,1636.8055.92%
3 Years9.9828.976.5317.2969,2258.9889.98%
5 Years9.9828.976.5317.2969,2258.9889.98%

Profound Medical Description

Profound Medical Corp is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. The company is commercializing TULSA-PRO, a technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while actively protecting the urethra and rectum to help preserve the patient's natural functional abilities. It is also commercializing Sonalleve, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

Your Recent History
Profound M..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.